These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17324242)

  • 21. Seizure following sudden zolpidem withdrawal.
    Cubała WJ; Landowski J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):539-40. PubMed ID: 16950552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Abuse, tolerance and dependence of zolpidem: three case reports].
    Correas Lauffer J; Braquehais Conesa D; Barbudo Del Cura E; Ochoa Mangada E
    Actas Esp Psiquiatr; 2002; 30(4):259-62. PubMed ID: 12217277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zolpidem for insomnia.
    Greenblatt DJ; Roth T
    Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel clinical pattern of visual hallucination after zolpidem use.
    Tsai MJ; Huang YB; Wu PC
    J Toxicol Clin Toxicol; 2003; 41(6):869-72. PubMed ID: 14677799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Writing emails as part of sleepwalking after increase in Zolpidem.
    Siddiqui F; Osuna E; Chokroverty S
    Sleep Med; 2009 Feb; 10(2):262-4. PubMed ID: 19059805
    [No Abstract]   [Full Text] [Related]  

  • 26. One rare side effect of zolpidem--sleepwalking: a case report.
    Yang W; Dollear M; Muthukrishnan SR
    Arch Phys Med Rehabil; 2005 Jun; 86(6):1265-6. PubMed ID: 15954071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High dose zolpidem induced fetal neural tube defects.
    Sharma A; Sayeed N; Khees CR; Akhtar S
    Curr Drug Saf; 2011 Apr; 6(2):128-9. PubMed ID: 21385155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive craving in high dose zolpidem dependency.
    Svitek J; Heberlein A; Bleich S; Wiltfang J; Kornhuber J; Hillemacher T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):591-2. PubMed ID: 18068286
    [No Abstract]   [Full Text] [Related]  

  • 29. Zolpidem and driving impairment--identifying persons at risk.
    Farkas RH; Unger EF; Temple R
    N Engl J Med; 2013 Aug; 369(8):689-91. PubMed ID: 23923991
    [No Abstract]   [Full Text] [Related]  

  • 30. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L; Eriksson M; Cornette F; Santoro F; Muscat N; Luthinger R; Roth T
    Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report.
    Aragona M
    Clin Neuropharmacol; 2000; 23(5):281-3. PubMed ID: 11154097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Scoring pharmacodependence seriousness: a novel CEIP's evaluation tool].
    Victorri-Vigneau C; Jolliet P
    Therapie; 2006; 61(6):517-22. PubMed ID: 17348608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA requires lower dosing of zolpidem.
    Med Lett Drugs Ther; 2013 Jan; 55(1408):5. PubMed ID: 23348358
    [No Abstract]   [Full Text] [Related]  

  • 36. Zolpidem: distinct from triazolam?
    Lobo BL; Greene WL
    Ann Pharmacother; 1997 May; 31(5):625-32. PubMed ID: 9161660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Unsatisfied craving: zolpidem (Stilnox) dependence syndrome].
    Hofmann M; Eichhorn M
    Psychiatr Prax; 1998 Nov; 25(6):313. PubMed ID: 9885847
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiological evidence for a low abuse potential of zolpidem.
    Soyka M; Bottlender R; Möller HJ
    Pharmacopsychiatry; 2000 Jul; 33(4):138-41. PubMed ID: 10958262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Significance of the sedative zolpidem in combination with alcohol and benzodiazepines in patients with physical dependence].
    Undén M
    Ugeskr Laeger; 1993 Dec; 155(51):4194-5. PubMed ID: 8273251
    [No Abstract]   [Full Text] [Related]  

  • 40. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.
    Hajak G; Müller WE; Wittchen HU; Pittrow D; Kirch W
    Addiction; 2003 Oct; 98(10):1371-8. PubMed ID: 14519173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.